WO2012168680A8 - Pharmaceutical preparation comprising recombinant fsh - Google Patents

Pharmaceutical preparation comprising recombinant fsh Download PDF

Info

Publication number
WO2012168680A8
WO2012168680A8 PCT/GB2012/000491 GB2012000491W WO2012168680A8 WO 2012168680 A8 WO2012168680 A8 WO 2012168680A8 GB 2012000491 W GB2012000491 W GB 2012000491W WO 2012168680 A8 WO2012168680 A8 WO 2012168680A8
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical preparation
recombinant fsh
fsh
glycan structures
recombinant
Prior art date
Application number
PCT/GB2012/000491
Other languages
French (fr)
Other versions
WO2012168680A1 (en
Inventor
Ian Cottingham
Daniel Plaksin
Bjorn Rikard Lorentz SANDSTROM
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Priority to EP12730594.4A priority Critical patent/EP2717904A1/en
Publication of WO2012168680A1 publication Critical patent/WO2012168680A1/en
Publication of WO2012168680A8 publication Critical patent/WO2012168680A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Preparations including FSH, for example recombinant FSH, wherein 17% to 23% of the sialyated glycan structures are tetra-sialylated glycan structures.
PCT/GB2012/000491 2011-06-06 2012-06-06 Pharmaceutical preparation comprising recombinant fsh WO2012168680A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12730594.4A EP2717904A1 (en) 2011-06-06 2012-06-06 Pharmaceutical preparation comprising recombinant fsh

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11168816 2011-06-06
EP11168816.4 2011-06-06

Publications (2)

Publication Number Publication Date
WO2012168680A1 WO2012168680A1 (en) 2012-12-13
WO2012168680A8 true WO2012168680A8 (en) 2014-01-03

Family

ID=46397316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2012/000491 WO2012168680A1 (en) 2011-06-06 2012-06-06 Pharmaceutical preparation comprising recombinant fsh

Country Status (3)

Country Link
EP (1) EP2717904A1 (en)
AR (1) AR090095A1 (en)
WO (1) WO2012168680A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348465B (en) * 2015-09-17 2020-11-10 葛莱高托普有限公司 Mammalian follicle stimulating hormone compositions with improved stability

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (en) 2008-04-16 2015-06-21 Ferring Int Ct Sa Pharmaceutical preparation
AU2018326556A1 (en) 2017-09-01 2020-03-05 Ferring B.V. Composition for controlled ovarian stimulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161235A0 (en) * 2001-10-22 2004-09-27 Applied Research Systems Fsh composition, its preparation and use
US8609370B2 (en) * 2004-02-13 2013-12-17 Glycotope Gmbh Highly active glycoproteins-process conditions and an efficient method for their production
TWI488640B (en) 2008-04-16 2015-06-21 Ferring Int Ct Sa Pharmaceutical preparation
TWI532495B (en) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 Pharmaceutical preparation
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348465B (en) * 2015-09-17 2020-11-10 葛莱高托普有限公司 Mammalian follicle stimulating hormone compositions with improved stability

Also Published As

Publication number Publication date
EP2717904A1 (en) 2014-04-16
WO2012168680A1 (en) 2012-12-13
AR090095A1 (en) 2014-10-22

Similar Documents

Publication Publication Date Title
EP4272746A3 (en) Crystal forms of beta-nicotinamide mononucleotide
WO2014052360A3 (en) Glycoprotein preparations
WO2013177419A3 (en) Lipid nanoparticle compositions and methods of making and methods of using the same
WO2011130615A3 (en) Preparation of lacosamide
WO2013063383A3 (en) Vectors encoding rod-derived cone viability factor
WO2013123114A3 (en) Anti-vla1 (cd49a) antibody pharmaceutical compositions
WO2012174158A3 (en) Administration of benzodiazepine
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
WO2013055684A8 (en) Rasagiline citramide
WO2014121040A8 (en) Flap modulators
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
HUP1300647A2 (en) Complexes of cyclosporine a and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
WO2014121055A3 (en) Flap modulators
HRP20181274T1 (en) Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process
WO2012168680A8 (en) Pharmaceutical preparation comprising recombinant fsh
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
WO2014022475A3 (en) Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
WO2011139752A3 (en) Preparation of polypeptides and salts thereof
WO2012131306A8 (en) Pharmaceutical preparation
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
WO2014030173A3 (en) Improved process for preparation of atazanavir bisulfate
WO2012138806A3 (en) Olive mill waste fractions, their preparation and uses
WO2012139074A3 (en) Migrastatins and uses thereof
WO2014076616A3 (en) Formulations of 5-azacytidine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12730594

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2012730594

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012730594

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: DE